STEELHEAD PARTNERS LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 24 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
STEELHEAD PARTNERS LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$35,287,880
-18.0%
41,000,000
-18.0%
2.07%
-24.2%
Q2 2023$43,056,250
+6.3%
50,000,000
+7.4%
2.73%
+3.5%
Q1 2023$40,485,659
-33.0%
46,562,000
-31.3%
2.64%
-40.1%
Q4 2022$60,446,929
+25.1%
67,736,000
+24.3%
4.40%
+23.1%
Q3 2022$48,311,000
+25.5%
54,500,000
+23.0%
3.58%
+8.3%
Q2 2022$38,486,000
-30.2%
44,298,000
-26.8%
3.30%
-12.9%
Q1 2022$55,131,00060,500,0003.79%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
BRAIDWELL LP 134,334,000$116,802,1483.85%
STEELHEAD PARTNERS LLC 46,562,000$40,485,6592.64%
DeepCurrents Investment Group LLC 40,000,000$34,578,4961.35%
WOLVERINE ASSET MANAGEMENT LLC 76,557,000$66,300,8520.78%
SHENKMAN CAPITAL MANAGEMENT INC 11,317,000$9,786,5210.74%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,856,000$4,199,9000.62%
Ionic Capital Management LLC 2,000,000$1,726,3490.50%
Empyrean Capital Partners, LP 15,000,000$12,980,0000.44%
Context Capital Management, LLC 4,489$3,9030.33%
Graham Capital Management, L.P. 11,422,000$9,875,7460.30%
View complete list of NOVOCURE LTD shareholders